Concentrix (NASDAQ:CNXC) Stock Rating Reaffirmed as Buy by Canaccord Genuity Group

Concentrix (NASDAQ:CNXC)‘s stock had its “buy” rating restated by investment analysts at Canaccord Genuity Group in a note issued to investors on Wednesday, Benzinga reports. They currently have a $45.00 price objective on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 66.60% from the company’s previous close.

CNXC has been the subject of a number of other reports. Bank of America reduced their target price on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research note on Tuesday, June 30th. Weiss Ratings reiterated a “sell (d)” rating on shares of Concentrix in a research note on Friday, July 24th. Barrington Research lowered their price target on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating on the stock in a report on Tuesday, June 30th. Zacks Research raised shares of Concentrix from a “strong sell” rating to a “hold” rating in a report on Monday, August 31st. Finally, Robert W. Baird decreased their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research note on Tuesday, June 30th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Concentrix presently has an average rating of “Hold” and a consensus price target of $33.50.

Concentrix Price Performance

NASDAQ CNXC traded up $2.06 during trading on Wednesday, reaching $27.01. 2,197,861 shares of the company traded hands, compared to its average volume of 1,658,617. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. The stock’s 50 day moving average price is $27.04 and its two-hundred day moving average price is $26.48. The company has a market cap of $1.65 billion, a price-to-earnings ratio of -0.69, a P/E/G ratio of 0.46 and a beta of 0.47. Concentrix has a 1-year low of $19.12 and a 1-year high of $49.37.

Concentrix (NASDAQ:CNXC) last posted its quarterly earnings data on Tuesday, September 29th. The company reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.71 by $0.21. The firm had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.48 billion. Concentrix had a negative net margin of 23.99% and a positive return on equity of 22.78%. Concentrix’s revenue was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.78 EPS. Concentrix has set its FY 2026 guidance at 10.970-11.090 EPS and its Q4 2026 guidance at 2.860-2.980 EPS. As a group, analysts anticipate that Concentrix will post 9.67 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CNXC. BlackRock Inc. bought a new position in shares of Concentrix during the 2nd quarter valued at approximately $149,639,000. Pzena Investment Management LLC bought a new position in shares of Concentrix in the 2nd quarter worth $76,488,000. Groupe Bruxelles Lambert bought a new position in shares of Concentrix during the 2nd quarter valued at $68,000,000. Kopernik Global Investors LLC bought a new position in shares of Concentrix during the 1st quarter valued at $44,523,000. Finally, Bank of America Corp DE bought a new stake in Concentrix in the 2nd quarter worth $18,248,000. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Concentrix

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix reported third-quarter adjusted EPS of $2.92, exceeding the $2.71 analyst consensus. Non-GAAP operating income was $309 million, indicating solid underlying profitability despite the reported GAAP loss. Concentrix Q3 2026 earnings results
• Positive Sentiment: Management highlighted continued momentum from AI-enabled services: roughly half of revenue now comes from business won since the company introduced AI tools, while new-business revenue is expected to exceed $6 billion in 2027. Concentrix earnings call highlights
• Positive Sentiment: The company increased its quarterly dividend to $0.37 per share from $0.36, supporting an annualized payout of $1.48 and a roughly 5.9% yield. Concentrix dividend and earnings coverage
• Positive Sentiment: Canaccord Genuity reaffirmed its Buy rating and assigned a $45 price target, suggesting substantial long-term upside if the AI transition improves growth and margins.
• Neutral Sentiment: Concentrix expects fiscal 2026 EPS of $10.97-$11.09 and fourth-quarter EPS of $2.86-$2.98, providing a relatively stable earnings outlook even as revenue growth remains pressured. Concentrix fiscal 2026 guidance
• Negative Sentiment: Third-quarter revenue declined 1.2% year over year to $2.45 billion, missing expectations of $2.48 billion. The company also reported a $1.05 billion goodwill charge, producing a $910.3 million operating loss and a sharply negative GAAP margin. Concentrix quarterly loss after goodwill charge
• Negative Sentiment: BofA Securities lowered its price target to $29, signaling limited near-term upside and continued concern about the slower revenue outlook. BofA lowers Concentrix price target

Concentrix Company Profile

Concentrix Corporation is a global technology and services company that helps organizations manage customer experience, business operations and digital transformation. Its offerings include customer care, technical support, sales and marketing services, back-office support, analytics, artificial intelligence and automation solutions.

The company serves clients across industries such as technology and consumer electronics, retail, banking and financial services, healthcare, communications and media, travel, and automotive.